|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Wyeth |
|---|---|
| Information provided by: | Wyeth |
| ClinicalTrials.gov Identifier: | NCT00081744 |
Purpose
Purpose: To provide a mechanism for the emergency use of tigecycline in the appropriate clinical situations.
| Condition | Intervention | Phase |
|---|---|---|
|
Gram-Positive Bacterial Infections Cross Infection |
Drug: Tigecycline |
Phase III |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Safety/Efficacy Study |
| Official Title: | A Multicenter, Double-Blind, Randomized Comparison Study Of the Efficacy and Safety of Tigecycline to Imipenem/ Cilastatin to Treat Complicated Intra-Abdominal Infections in Hospitalized Subjects |
Eligibility| Ages Eligible for Study: | 8 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations
More Information
| Study ID Numbers: | 3074A1-301 |
| Study First Received: | April 19, 2004 |
| Last Updated: | May 17, 2006 |
| ClinicalTrials.gov Identifier: | NCT00081744 History of Changes |
| Health Authority: | United States: Food and Drug Administration |
|
Bacterial Infections |
|
Bacterial Infections Anti-Bacterial Agents Gram-Positive Bacterial Infections Tigecycline |
Cilastatin Cross Infection Imipenem |
|
Bacterial Infections Anti-Infective Agents Anti-Bacterial Agents Communicable Diseases Gram-Positive Bacterial Infections |
Tigecycline Therapeutic Uses Infection Pharmacologic Actions Cross Infection |